Tolerance Bio

Philadelphia, United States

Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus.

Jun 2026

Seed

Top Investors

Columbus Venture Partners BioAdvance Ben Franklin Technology Partners of Northeastern Pennsylvania Criteria Bio Ventures Beyond Celiac Investments

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tolerance Bio

Who are Tolerance Bio's investors?

Tolerance Bio's investors include Columbus Venture Partners, BioAdvance, Ben Franklin Technology Partners of Northeastern Pennsylvania, Criteria Bio Ventures, Beyond Celiac Investments.

Where is Tolerance Bio headquartered?

Tolerance Bio is headquartered in Philadelphia, United States.

What does Tolerance Bio do?

Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus.

What stage is Tolerance Bio at?

Tolerance Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 22, 2026.

MLA

"Tolerance Bio — Funding & Investors." VCBacked, June 22, 2026, https://www.vcbacked.co/company/tolerance-bio. Accessed July 18, 2026.

APA

VCBacked. (2026). Tolerance Bio — Funding & Investors. Retrieved July 18, 2026, from https://www.vcbacked.co/company/tolerance-bio

Wikipedia (cite web)

{{cite web |title=Tolerance Bio — Funding & Investors |url=https://www.vcbacked.co/company/tolerance-bio |website=VCBacked |access-date=July 18, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 22, 2026.